Department of Cardiology, Laboratory of Experimental Cardiology, UMC Utrecht Regenerative Medicine Centre, University Medical Centre Utrecht, University Utrecht, Utrecht, the Netherlands.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; INEB - Instituto Nacional de Engenharia Biomédica, Universidade do Porto, Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal; CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands; IMAiA - Institute of Molecular Biology and RNA Technology, Faculty of Sciences and Engineering, Maastricht University, Maastricht, the Netherlands.
Biochim Biophys Acta Mol Cell Res. 2020 Mar;1867(3):118515. doi: 10.1016/j.bbamcr.2019.07.010. Epub 2019 Jul 27.
Heart failure (HF) as a result of myocardial infarction (MI) is the leading cause of death worldwide. In contrast to the adult mammalian heart, which has low regenerative capacity, newborn mammalian and zebrafish hearts can completely regenerate after injury. Cardiac regeneration is considered to be mediated by proliferation of pre-existing cardiomyocytes (CMs) mainly located in a hypoxic niche. To find new therapies to treat HF, efforts are being made to understand the molecular pathways underlying the regenerative capacity of the heart. However, the multicellularity of the heart is important during cardiac regeneration as not only CM proliferation but also the restoration of the endothelium is imperative to prevent progression to HF. It has recently come to light that signalling from non-coding RNAs (ncRNAs) and extracellular vesicles (EVs) plays a role in the healthy and the diseased heart. Multiple studies identified differentially expressed ncRNAs after MI, making them potential therapeutic targets. In this review, we highlight the molecular interactions between endothelial cells (ECs) and CMs in cardiac regeneration and when the heart loses its regenerative capacity. We specifically emphasize the role of ncRNAs and cell-cell communication via EVs during cardiac regeneration and neovascularisation.
心肌梗死导致的心力衰竭(HF)是全球范围内导致死亡的主要原因。与成年哺乳动物心脏的再生能力低不同,新生哺乳动物和斑马鱼的心脏在受伤后可以完全再生。心脏再生被认为是由主要位于缺氧龛中的预先存在的心肌细胞(CMs)的增殖介导的。为了寻找治疗 HF 的新疗法,人们正在努力了解心脏再生能力的分子途径。然而,心脏的多细胞性在心脏再生过程中很重要,因为不仅 CM 增殖,而且内皮细胞的恢复对于防止进展为 HF 也是至关重要的。最近发现,非编码 RNA(ncRNAs)和细胞外囊泡(EVs)的信号在健康和患病心脏中都发挥作用。多项研究在 MI 后鉴定出差异表达的 ncRNAs,使它们成为潜在的治疗靶点。在这篇综述中,我们强调了心脏再生和心脏失去再生能力时 ECs 和 CMs 之间的分子相互作用。我们特别强调了 ncRNAs 在心脏再生和血管新生过程中的作用以及 EVs 介导的细胞间通讯。